CD274 and neoplasm: When PD-L1 status was analyzed, 35% of patients with a PD-L1 tumor proportion score (TPS) < 1% and 55% of patients with a TPS ≥ 1 were seen to have an objective response, suggesting that upregulated PD-L1 expression is not necessary for anti-tumor activity.